# Monopar Therapeutics > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/monopar-therapeutics | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 23 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-24T04:46:20.339259+00:00 | | Last reviewed | 2026-10-24T04:46:20.339259+00:00 | ## Identity - Legal name: Monopar Therapeutics - Display name: Monopar Therapeutics ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-24T18:03:20.547899+00:00 | | Completeness | 0.409 | | Record Quality | 0.83 | | Directors | 6 | | Committees | 6 | | Governance events | 13 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Arthur J. Klausner, MBA: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance · Chair (member); Compensation (member); Nominating and Governance (chair). claim_id=alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:5 - Chandler D. Robinson, MD MBA MSc: Director. Status: current. Independent: false. Since: 2014-01-01. claim_id=alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:6 - Christopher M. Starr, PhD: Director. Status: current. Independent: true. Since: 2014-01-01. claim_id=alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:7 - Kim R. Tsuchimoto: Director. Status: current. Independent: true. Since: 2023-01-01. claim_id=alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:8 - Lavina Talukdar, CFA: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:9 - Raymond W. Anderson, MBA MS: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Audit (chair); Audit · Chair; Compensation · Chair; Nominating and Governance (member); Compensation (chair); Nominating and Governance (member). claim_id=alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:10 ## Committees - Audit (audit). Chair: Raymond W. Anderson, MBA MS. Members: Raymond W. Anderson, MBA MS (chair, current); Arthur J. Klausner, MBA (member, current); Lavina Talukdar, CFA (member, current). committee_id=alpha:committee:monopar-therapeutics:audit - Audit · Chair; Compensation · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Raymond W. Anderson, MBA MS (member, current). committee_id=alpha:committee:monopar-therapeutics:audit-chair-compensation-chair-nominating-and-governance - Audit; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Lavina Talukdar, CFA (member, current). committee_id=alpha:committee:monopar-therapeutics:audit-compensation-nominating-and-governance - Audit; Compensation; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Arthur J. Klausner, MBA (member, current). committee_id=alpha:committee:monopar-therapeutics:audit-compensation-nominating-and-governance-chair - Compensation (compensation). Chair: Raymond W. Anderson, MBA MS. Members: Raymond W. Anderson, MBA MS (chair, current); Arthur J. Klausner, MBA (member, current); Lavina Talukdar, CFA (member, current). committee_id=alpha:committee:monopar-therapeutics:compensation - Nominating and Governance (nominating_governance). Chair: Arthur J. Klausner, MBA. Members: Arthur J. Klausner, MBA (chair, current); Lavina Talukdar, CFA (member, current); Raymond W. Anderson, MBA MS (member, current). committee_id=alpha:committee:monopar-therapeutics:nominating-and-governance ## Executive leadership - Chandler D. Robinson: CEO, Co-Founder and Director [CEO]. Status: current. claim_id=alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:11 ## Governance events - CEO_CHANGED: Chandler D. Robinson executive of Monopar Therapeutics, effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-24T04:46:20.339259+00:00. event_id=alpha:event:transition:bspeos1ne1524 - DIRECTOR_APPOINTED: Lavina Talukdar, CFA seat on Monopar Therapeutics, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-24T04:46:20.339259+00:00. event_id=alpha:event:transition:14dp2a61idx4t6 - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance committee of Monopar Therapeutics, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-24T04:46:20.339259+00:00. event_id=alpha:event:transition:x3krn8anqv4m - COMMITTEE_MEMBER_ADDED: Lavina Talukdar, CFA member of Audit; Compensation; Nominating and Governance, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-24T04:46:20.339259+00:00. event_id=alpha:event:transition:1rb8t6u1blzf3u - DIRECTOR_APPOINTED: Kim R. Tsuchimoto seat on Monopar Therapeutics, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-24T04:46:20.339259+00:00. event_id=alpha:event:transition:1ii7eav1jgc5bd - DIRECTOR_APPOINTED: Arthur J. Klausner, MBA seat on Monopar Therapeutics, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:46:20.339259+00:00. event_id=alpha:event:transition:v2w7ml59y6wz - DIRECTOR_APPOINTED: Raymond W. Anderson, MBA MS seat on Monopar Therapeutics, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:46:20.339259+00:00. event_id=alpha:event:transition:1bj7l0thi6um7 - COMMITTEE_CREATED: Audit · Chair; Compensation · Chair; Nominating and Governance committee of Monopar Therapeutics, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:46:20.339259+00:00. event_id=alpha:event:transition:geha851o51pyf - COMMITTEE_MEMBER_ADDED: Raymond W. Anderson, MBA MS member of Audit · Chair; Compensation · Chair; Nominating and Governance, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:46:20.339259+00:00. event_id=alpha:event:transition:mhx3qx1e322yv - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance · Chair committee of Monopar Therapeutics, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:46:20.339259+00:00. event_id=alpha:event:transition:1f8z9cnkoak9b - COMMITTEE_MEMBER_ADDED: Arthur J. Klausner, MBA member of Audit; Compensation; Nominating and Governance · Chair, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:46:20.339259+00:00. event_id=alpha:event:transition:1fkq7o314arfxn - DIRECTOR_APPOINTED: Chandler D. Robinson, MD MBA MSc seat on Monopar Therapeutics, effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-24T04:46:20.339259+00:00. event_id=alpha:event:transition:sqb6db1jypw5b - DIRECTOR_APPOINTED: Christopher M. Starr, PhD seat on Monopar Therapeutics, effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-24T04:46:20.339259+00:00. event_id=alpha:event:transition:nna3qk4ssgt6 ## Scoped resources - `alpha://company/monopar-therapeutics` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record - `alpha://company/monopar-therapeutics/identity` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=identity - `alpha://company/monopar-therapeutics/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=corporate-structure - `alpha://company/monopar-therapeutics/board` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=board - `alpha://company/monopar-therapeutics/committees` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=committees - `alpha://company/monopar-therapeutics/leadership` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=leadership - `alpha://company/monopar-therapeutics/ownership` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=ownership - `alpha://company/monopar-therapeutics/financials` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=financials - `alpha://company/monopar-therapeutics/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=capital-structure - `alpha://company/monopar-therapeutics/compensation` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=compensation - `alpha://company/monopar-therapeutics/governance` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=governance - `alpha://company/monopar-therapeutics/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=shareholder-governance - `alpha://company/monopar-therapeutics/audit` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=audit - `alpha://company/monopar-therapeutics/legal` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=legal - `alpha://company/monopar-therapeutics/risk` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=risk - `alpha://company/monopar-therapeutics/cyber` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=cyber - `alpha://company/monopar-therapeutics/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=ai-governance - `alpha://company/monopar-therapeutics/agents` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=agents - `alpha://company/monopar-therapeutics/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=ecosystem - `alpha://company/monopar-therapeutics/events` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=events - `alpha://company/monopar-therapeutics/relationships` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=relationships - `alpha://company/monopar-therapeutics/assessments` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=assessments - `alpha://company/monopar-therapeutics/evidence` (contract): https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:13: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:raymond-w-anderson-mba-ms","name":"Raymond W. Anderson, MBA MS"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:arthur-j-klausner-mba","name":"Arthur J. Klausner, MBA"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:lavina-talukdar-cfa","name":"Lavina Talukdar, CFA"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:raymond-w-anderson-mba-ms","name":"Raymond W. Anderson, MBA MS"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:arthur-j-klausner-mba","name":"Arthur J. Klausner, MBA"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:lavina-talukdar-cfa","name":"Lavina Talukdar, CFA"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:arthur-j-klausner-mba","name":"Arthur J. Klausner, MBA"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:lavina-talukdar-cfa","name":"Lavina Talukdar, CFA"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:raymond-w-anderson-mba-ms","name":"Raymond W. Anderson, MBA MS"},"source_id":"board_seats"}` ## Leadership - Arthur J. Klausner, MBA: Director, Audit; Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:5. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595. - Chandler D. Robinson, MD MBA MSc: Director. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:6. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595. - Christopher M. Starr, PhD: Director. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:7. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595. - Kim R. Tsuchimoto: Director. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:8. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595. - Lavina Talukdar, CFA: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:9. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595. - Raymond W. Anderson, MBA MS: Director, Audit · Chair; Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:10. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595. - Chandler D. Robinson: CEO, Co-Founder and Director. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:11. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5756921eb9832fa7296bf1bd1883cb513e9fe5a4af39dab2734db553a501c421. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Raymond W. Anderson, MBA MS; Members Raymond W. Anderson, MBA MS (Chair); Arthur J. Klausner, MBA; Lavina Talukdar, CFA. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_record:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2446c10d42fb2e87c25849c4346fa34c350c65800547cf39c660584c9ce55ef0. - Compensation: Chair Raymond W. Anderson, MBA MS; Members Raymond W. Anderson, MBA MS (Chair); Arthur J. Klausner, MBA; Lavina Talukdar, CFA. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2446c10d42fb2e87c25849c4346fa34c350c65800547cf39c660584c9ce55ef0. - Nominating and Governance: Chair Arthur J. Klausner, MBA; Members Arthur J. Klausner, MBA (Chair); Lavina Talukdar, CFA; Raymond W. Anderson, MBA MS. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2446c10d42fb2e87c25849c4346fa34c350c65800547cf39c660584c9ce55ef0. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Monopar Therapeutics. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3451d0acf5070abf4635b0264096951ee151f5e508ee2fae068c5f510f72c3c3. ## Entity Status - Public listing published. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3451d0acf5070abf4635b0264096951ee151f5e508ee2fae068c5f510f72c3c3. ## Published Fact - US. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3451d0acf5070abf4635b0264096951ee151f5e508ee2fae068c5f510f72c3c3. ## Committee Appointment - Raymond W. Anderson, MBA MS: chair, Audit. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2446c10d42fb2e87c25849c4346fa34c350c65800547cf39c660584c9ce55ef0. - Arthur J. Klausner, MBA: member, Audit. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2446c10d42fb2e87c25849c4346fa34c350c65800547cf39c660584c9ce55ef0. - Lavina Talukdar, CFA: member, Audit. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2446c10d42fb2e87c25849c4346fa34c350c65800547cf39c660584c9ce55ef0. - Raymond W. Anderson, MBA MS: chair, Compensation. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2446c10d42fb2e87c25849c4346fa34c350c65800547cf39c660584c9ce55ef0. - Arthur J. Klausner, MBA: member, Compensation. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2446c10d42fb2e87c25849c4346fa34c350c65800547cf39c660584c9ce55ef0. - Lavina Talukdar, CFA: member, Compensation. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2446c10d42fb2e87c25849c4346fa34c350c65800547cf39c660584c9ce55ef0. - Arthur J. Klausner, MBA: chair, Nominating and Governance. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2446c10d42fb2e87c25849c4346fa34c350c65800547cf39c660584c9ce55ef0. - Lavina Talukdar, CFA: member, Nominating and Governance. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2446c10d42fb2e87c25849c4346fa34c350c65800547cf39c660584c9ce55ef0. - Raymond W. Anderson, MBA MS: member, Nominating and Governance. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2446c10d42fb2e87c25849c4346fa34c350c65800547cf39c660584c9ce55ef0. ## Security Listing - MNPR (NASDAQ). Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3451d0acf5070abf4635b0264096951ee151f5e508ee2fae068c5f510f72c3c3. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:3451d0acf5070abf4635b0264096951ee151f5e508ee2fae068c5f510f72c3c3: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/monopar-therapeutics). - alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595: [Monopar Therapeutics DEF 14A 2025-04-30](https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm). - alpha:projection-evidence:document:5756921eb9832fa7296bf1bd1883cb513e9fe5a4af39dab2734db553a501c421: [MNPR DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1645469/000143774926014183/mnpr20260330_def14a.htm). - alpha:projection-evidence:2446c10d42fb2e87c25849c4346fa34c350c65800547cf39c660584c9ce55ef0: [Audit](https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/monopar-therapeutics) - [Public Markdown](https://registry.alpha.ac/companies/monopar-therapeutics.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=jsonld) - MCP resource: `alpha://companies/monopar-therapeutics` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-24T18:03:20.289919+00:00; recorded 2026-10-24T18:03:20.289919+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.